BLUEJET vs HALEOSLABS: Stock Comparison

BLUE JET HEALTHCARE vs HALEOS LABSUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

BLUE JET HEALTHCARE is the larger company by market capitalisation. BLUE JET HEALTHCARE shows a higher ROE, a higher dividend yield and lower leverage, while HALEOS LABS shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BLUEJET leads 6; HALEOSLABS leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BLUEJETHALEOSLABS

Valuation lens

What price are you paying?

Market CapContext only
₹10,778 Cr
₹443 Cr
P/E RatioSame reading
0x
0x
P/B RatioSame reading
0x
0x
EPSHALEOSLABS has the higher reading
₹4.51
₹10.71
Book ValueContext only
₹78.4
₹759.29
Dividend YieldBLUEJET has the higher reading
0.21%
0.1%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BLUEJET is the larger company
₹10,778 Cr vs ₹443 Cr
EPS
HALEOSLABS has higher earnings per share
₹10.71 vs ₹4.51
Dividend Yield
BLUEJET has a higher dividend yield
0.21% vs 0.1%
Revenue Growth (TTM YoY)
HALEOSLABS has faster revenue growth
0% vs -31.1%
EPS Growth (TTM YoY)
HALEOSLABS has faster EPS growth
0% vs -41.5%
Qtr Sales Growth
HALEOSLABS has stronger quarterly sales growth
-7.01% vs -69.06%
Qtr Profit Growth
HALEOSLABS has stronger quarterly profit growth
75.94% vs -68.42%
ROE
BLUEJET has a higher ROE
18.22% vs 8.28%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBLUEJETHALEOSLABS
SectorHealthcare
IndustryPharmaceuticals

Price

MetricBLUEJETHALEOSLABS
Live Price₹569.8₹1,451.3
Day Change-1.59%-2.08%
Volume4.42 L5,164
52-Week High₹759.5₹1,774
52-Week Low₹325₹1,181
Distance from 52W High-24.98%-18.19%

Valuation

MetricBLUEJETHALEOSLABS
Market Cap₹10,778 Cr₹443 Cr
P/E Ratio0x0x
P/B Ratio0x0x
EPS₹4.51₹10.71
Book Value₹78.4₹759.29
Dividend Yield0.21%0.1%

Growth

MetricBLUEJETHALEOSLABS
Revenue Growth (TTM YoY)-31.1%0%
EPS Growth (TTM YoY)-41.5%0%
Qtr Sales Growth-69.06%-7.01%
Qtr Profit Growth-68.42%75.94%

Profitability & Leverage

MetricBLUEJETHALEOSLABS
ROE18.22%8.28%
ROCE19.25%7.15%
Net Margin27.25%5.33%
Operating Margin35.76%10.37%
Debt to Equity0x0.43x

Shareholding

As of Jul 2026 • change vs previous quarter
MetricBLUEJETHALEOSLABS
Promoter Holding73.15% 6.66 pp72.11%
FII Holding0.62% 0.22 pp0%
DII Holding9.12% 4.47 pp0.31% 0.01 pp
Public Holding17.11% 1.97 pp27.58% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BLUE JET HEALTHCARE and HALEOS LABS.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.